Investor Relations header Spectrum Pharmaceuticals Investor Relations picture
      
Oncology, Generics, Neurology Drugs About Spectrum Pharmaceuticals SPPI Investor Relations SPPI News
shadow area

Contact Us

Primary IR Contact
Investor Relations
Phone: (949)788-6700
E-mail: IR@sppirx.com

Questions for the Investor Relations Department can be submitted through the form below. Fields marked with an * are required.

 
 
 
 
 
 
This helps Spectrum Pharmaceuticals, Inc. prevent automated submissions.
 
Stock Information
NASDAQ:SPPI
$14.35   + 0.15
Feb 3, 2012
4:00 PM ET
Quotes delayed at least 20 minutes.
Information provided by eSignal.
Shareholder Tools

Search Investor Relations



 All contents © Copyright Spectrum Pharmaceuticals, Inc. 2012. All Rights Reserved.  Terms of Use